Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

10,744 total articles

IperionX Executive Chairman Executes $2.08 Million Share Acquisition

IperionX Executive Chairman Executes $2.08 Million Share Acquisition

Todd Hannigan, the Executive Chairman of IperionX Ltd (NASDAQ: IPX), has completed a significant acquisition of ordinary shares totaling approximately $2,077,784. The buying activity occurred over a two-day period on the Australian Stock Exchange, signaling substantial personal investment by one of the company's top executives.The transactions were…

Natera CFO Executes $1 Million in Common Stock Sales

Natera CFO Executes $1 Million in Common Stock Sales

Michael Burkes Brophy, the Chief Financial Officer of Natera, Inc. (NASDAQ: NTRA), has completed the sale of 5,063 shares of the company's common stock. The transactions, which took place in late April 2026, resulted in total proceeds of approximately $1,001,645. The sales were executed at varying price points between $190.115 and $204.39 per share…

Natera Executive Executes Stock Sale Following RSU Vesting

Natera Executive Executes Stock Sale Following RSU Vesting

John Fesko, who serves as the President and Chief Business Officer of Natera, Inc. (NASDAQ:NTRA), has completed a sale of company shares totaling $344,516. The transaction, which occurred on April 27, 2026, involved the sale of 1,688 shares of common stock. According to recent SEC filings, these sales were executed under a pre-arranged Rule 10b5-1 …

Natera Executive Executes Share Sales for Tax Obligations

Natera Executive Executes Share Sales for Tax Obligations

Solomon Moshkevich, the President of Clinical Diagnostics at Natera, Inc. (NASDAQ:NTRA), completed two transactions involving the sale of 2,182 shares of company common stock on April 27, 2026. The total value of these sales amounted to $445,340, with share prices falling between $203.75 and $204.39. These disposals were executed via pre-arranged w…

Estrella Immunopharma CFO Executes Recent Common Stock Purchases

Estrella Immunopharma CFO Executes Recent Common Stock Purchases

Xu Jiandong, the Chief Financial Officer of Estrella Immunopharma, Inc. (NASDAQ:ESLA), has completed several transactions to acquire additional shares of the company's common stock. These acquisitions, occurring in late 2025, involved both direct and indirect holdings. While these moves represent an increase in insider positioning, the company’s st…